Again DYOR.
Digging a bit, and found this https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374002
An old cu67/cu64 Australia Trial at Royal North Shore, by Dr Geoffrey Schembri, closed early because of difficulty of recruitment,
Found this
https://jnm.snmjournals.org/content/60/supplement_1/1624a
Not primary or secondary outcome I can see from the ANZCTR listing.
So far; cant seem to be able to find any publications or papers about the results, how many patients were treated, any luck with no PD, or stable?
I am hoping these type of treatments will be helpful for people who need it, as tertiary or last line.
Cancer is a cr@p disease to have.
Again, just offering another view point. DYOR
ASX: CU6 Outlook., page-20
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.65 |
Change
-0.050(0.57%) |
Mkt cap ! $2.734B | |||
| Open | High | Low | Value | Volume |
| $8.65 | $8.79 | $8.40 | $14.40M | 1.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59 | $8.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.65 | 21036 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |